1. Home
  2. TUSK vs MNOV Comparison

TUSK vs MNOV Comparison

Compare TUSK & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mammoth Energy Services Inc.

TUSK

Mammoth Energy Services Inc.

N/A

Current Price

$2.83

Market Cap

137.3M

Sector

Energy

ML Signal

N/A

Logo Medicinova Inc

MNOV

Medicinova Inc

N/A

Current Price

$1.66

Market Cap

137.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TUSK
MNOV
Founded
2014
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.3M
137.8M
IPO Year
2016
2004

Fundamental Metrics

Financial Performance
Metric
TUSK
MNOV
Price
$2.83
$1.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $8.25
AVG Volume (30 Days)
73.9K
★ 792.7K
Earning Date
10-30-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 102.32
N/A
EPS
★ 0.09
N/A
Revenue
★ $44,292,000.00
$2,360,807.00
Revenue This Year
N/A
$78.20
Revenue Next Year
N/A
N/A
P/E Ratio
$32.56
★ N/A
Revenue Growth
N/A
★ 194.15
52 Week Low
$1.72
$1.17
52 Week High
$3.92
$3.90

Technical Indicators

Market Signals
Indicator
TUSK
MNOV
Relative Strength Index (RSI) 37.46 40.69
Support Level $2.80 $1.28
Resistance Level $2.94 $3.90
Average True Range (ATR) 0.11 0.37
MACD -0.03 -0.14
Stochastic Oscillator 7.07 1.56

Price Performance

Historical Comparison
TUSK
MNOV

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes rental services, infrastructure services, natural sand proppant services, accommodation services, and drilling services.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: